3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Neoplasms
1
Prostatic Diseases
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Myelodysplastic Syndromes
1
Male Urogenital Diseases
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
Genital Diseases, Male
1
Interventions
Fulvestrant
5
serabelisib
2
sapanisertib
2
ribociclib
2
palbociclib
2
Paclitaxel
2
Letrozole
2
Irinotecan
2
Gemcitabine
2
Carboplatin
2
Alpelisib
2
venetoclax
1
tivozanib
1
tipifarnib
1
sotorasib
1
pembrolizumab
1
olaparib
1
niraparib
1
lorlatinib
1
liposomal doxorubicin
1
inavolisib
1
exemestane
1
encorafenib
1
ceralasertib
1
cemiplimab
1
capivasertib
1
binimetinib
1
abemaciclib
1
Taxes
1
Tamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
gedatolisib
×
1 year
×
Clear all
No trials found.